NASDAQ: PHAR
Pharming Group Nv Stock Ownership - Who owns Pharming Group Nv?

Insider buying vs selling

Have Pharming Group Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PHAR insiders and whales buy or sell their stock.

PHAR Shareholders

What type of owners hold Pharming Group Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mac Alpha Capital Management LP0.00%2,148$26.27kInstitution
Macalp0.00%2,148$26.27kInstitution
Silber0.00%42$513.66Institution
Silverberg Bernstein Capital Management LLC0.00%41$501.43Institution
Crossmark Global Holdings Inc0.00%12$146.76Institution
Citadel Advisors LLC0.00%12$146.76Institution
Crossm0.00%12$146.76Institution
Citade0.00%12$146.76Institution
Morsta0.00%12$146.76Institution
Morgan Stanley0.00%11$134.53Institution

1 of 4

PHAR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHAR0.00%0.00%
IVA0.04%0.00%
LTGO0.00%28.86%Net BuyingNet Buying
GLUE0.08%99.92%Net SellingNet Selling
MGTX0.08%50.18%Net SellingNet Selling

Pharming Group Nv Stock Ownership FAQ

Who owns Pharming Group Nv?

Pharming Group Nv (NASDAQ: PHAR) is owned by 0.00% institutional shareholders, 0.00% Pharming Group Nv insiders, and 100.00% retail investors. Mac Alpha Capital Management LP is the largest individual Pharming Group Nv shareholder, owning 2148.00 shares representing 0.00% of the company. Mac Alpha Capital Management LP's Pharming Group Nv shares are currently valued at $27.34k.

If you're new to stock investing, here's how to buy Pharming Group Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.